USANA Health Sciences, Inc.
USANA Makes Major Announcements at 16th Annual International Convention
Published in Law and Health Weekly, September 20th, 2008
As part of the event, USANA unveiled its new Rev3 Energy(TM) drink, revealed additions to its already lucrative compensation plan and announced its plan to enter the Philippines in early 2009.
Rev3 Energy(TM) is an advanced formula of antioxidants and other important nutrients packed in a delicious beverage that contains no artificial flavors, colors, sweeteners or preservatives. The product is green tea-based, providing consumers with a natural lift. Rev3 Energy is available in a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- A.M. Best Co.
A.M. Best Affirms and Assigns Ratings to AMERIGROUP Corporation's HMO Subsidiaries - Abigail Adams National Bancorp
Jeanne Delaney Hubbard Resigns from Her Positions with Abigail Adams National Bancorp - Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals Completes Second Closing of Senior Convertible Debt Financing - AIDS Healthcare Foundation and CA Assembly Member Paul Krekorian's office
California Law to Compel Insurers to Cover Routine HIV Tests Is First in Nation - Akerman Senterfitt
Akerman Senterfitt and WolfBlock Discussions Terminated - Alpharma Inc.
Alpharma Adopts Limited Duration Shareholder Rights Plan - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
